Efficacy of antiplatelets in deep venous thrombosis

Venous thromboembolism (VTE) is the third most common cardiovascular disease in the world. Every year, 30,000 people in Australia develop VTE, at a cost of $1.72 billion to the Australian health system.

Caring for our elders

This Royal Commission is an opportunity to improve how we care for our elderly, and release the chains holding pharmacists back from preventing inappropriate...

Antimicrobial use up in disadvantaged areas

Antimicrobial medicines use declined in Australia from 2013 to 2018, but the country’s rate remains high by OECD standards, according to new research.

Transforming medicine safety in aged care

PSA’s 2025 Early Career Pharmacist of the Year, Dr Kate Wang is shaping pharmacy education and aged care policy.

Nasal swab offers hope for reducing vancomycin use

A study has found a pharmacy-driven protocol using nasal swabs to assess methicillin‑resistant Staphylococcus aureus (MRSA) in pneumonia cases holds promise for reducing unnecessary...

Young sparks light up pharmacy future

The future of pharmacy is bright, engaged and passionate, the search for the latest PSA MIMS Intern Pharmacist of the Year has revealed. Judges were...